Orion Oyj

Director's Dealing • May 11, 2023

Disclosure 433017

Orion - Managers' transactions

Orion Corporation: Managers' transactions - Agendum Oy

ORION CORPORATION

MANAGERS’ TRANSACTIONS

11 MAY 2023 at 15.30 EEST

Orion Corporation: Managers’ transactions – Agendum Oy

Orion Corporation has received the following disclosure under Market Abuse Regulation (EU) No 596/2014, regarding transactions with shares and linked securities in Orion Corporation made by managers and their closely associated persons.

Orion Oyj - Managers' Transactions

____________________________________________

Person subject to the notification requirement

Name: Agendum Oy

Position: Closely associated person

(X) Legal person (1):Person Discharging Managerial Responsibilities In Issuer

Name: Mikael Silvennoinen

Position: Member of the Board

Issuer: Orion Oyj

LEI: 74370029VAHCXDR7B745

Notification type: INITIAL NOTIFICATION

Reference number: 31439/4/6

____________________________________________

Transaction date: 2023-05-09

Venue: NASDAQ HELSINKI LTD (XHEL)

Instrument type: SHARE

ISIN: FI0009014377

Nature of transaction: ACQUISITION

Transaction details

(1): Volume: 85 Unit price: 43.22 EUR

(2): Volume: 36 Unit price: 43.22 EUR

(3): Volume: 151 Unit price: 43.22 EUR

(4): Volume: 151 Unit price: 43.22 EUR

(5): Volume: 175 Unit price: 43.22 EUR

(6): Volume: 120 Unit price: 43.21 EUR

(7): Volume: 151 Unit price: 43.21 EUR

(8): Volume: 63 Unit price: 43.21 EUR

(9): Volume: 175 Unit price: 43.21 EUR

(10): Volume: 2 Unit price: 43.19 EUR

Aggregated transactions (10):

Volume: 1109 Volume weighted average price: 43.21536 EUR

____________________________________________

Transaction date: 2023-05-09

Venue: TQEX

Instrument type: SHARE

ISIN: FI0009014377

Nature of transaction: ACQUISITION

Transaction details

(1): Volume: 38 Unit price: 43.21 EUR

Aggregated transactions (1):

Volume: 38 Volume weighted average price: 43.21 EUR

____________________________________________

Transaction date: 2023-05-09

Venue: CEUX

Instrument type: SHARE

ISIN: FI0009014377

Nature of transaction: ACQUISITION

Transaction details

(1): Volume: 21 Unit price: 43.21 EUR

(2): Volume: 154 Unit price: 43.21 EUR

(3): Volume: 21 Unit price: 43.2 EUR

(4): Volume: 154 Unit price: 43.2 EUR

(5): Volume: 30 Unit price: 43.19 EUR

Aggregated transactions (5):

Volume: 380 Volume weighted average price: 43.20382 EUR

____________________________________________

Transaction date: 2023-05-09

Venue: AQEU

Instrument type: SHARE

ISIN: FI0009014377

Nature of transaction: ACQUISITION

Transaction details

(1): Volume: 125 Unit price: 43.22 EUR

(2): Volume: 107 Unit price: 43.2 EUR

Aggregated transactions (2):

Volume: 232 Volume weighted average price: 43.21078 EUR

Orion Corporation

Liisa Hurme President and CEO		Olli Huotari SVP, Corporate Functions

Publisher:

Orion Corporation

Communications

Orionintie 1A, FI-02200 Espoo, Finland

http://www.orion.fi/en

http://www.twitter.com/OrionCorpIR

Orion is a globally operating Finnish pharmaceutical company – a builder of well-being. We develop, manufacture and market human and veterinary pharmaceuticals and active pharmaceutical ingredients. Orion has an extensive portfolio of proprietary and generic medicines and self-care products. The core therapy areas of our pharmaceutical R&D are oncology and pain. Proprietary products developed by Orion are used to treat cancer, neurological diseases and respiratory diseases, among others. Orion's net sales in 2022 amounted to EUR 1,341 million and the company had about 3,500 employees at the end of the year. Orion's A and B shares are listed on Nasdaq Helsinki.